Related Experiment Video

Updated: May 6, 2026

Development of Recombinant Proteins to Treat Chronic Pain
10:37

Development of Recombinant Proteins to Treat Chronic Pain

Published on: April 11, 2018

9.2K

Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain

Huijing Wang, Cobi J Heijnen, Cindy T J van Velthoven

    The Journal of Clinical Investigation
    |November 16, 2013
    PubMed

    Insights

    Reducing GRK2 or increasing EPAC1 in sensory neurons promotes chronic pain. Restoring GRK2 or reducing EPAC1 levels may prevent and treat chronic pain conditions.

    Area of Science:

    • Neuroscience
    • Pain Research
    • Molecular Biology

    Background:

    • Chronic pain mechanisms, particularly the transition from acute to chronic pain, are not fully understood.
    • GPCR kinase 2 (GRK2) and EPAC1 signaling in nociceptors are implicated in pain sensitivity.
    • Reduced GRK2 and increased EPAC1 in nociceptors may drive chronic pain development.

    Purpose of the Study:

    • To investigate the role of GRK2 and EPAC1 in dorsal root ganglion (DRG) neurons in the transition to chronic pain.
    • To test the hypothesis that reduced GRK2 or increased EPAC1 promotes chronic pain.
    • To evaluate therapeutic strategies targeting GRK2 and EPAC1 for chronic pain.

    Main Methods:

    • Utilized two mouse models of hyperalgesic priming (carrageenan and PKCε agonist ΨεRACK).
    • Manipulated GRK2 and EPAC1 levels in vivo using viral gene transfer, gene heterozygosity, and antisense oligodeoxynucleotides.
    • Assessed chronic inflammatory pain using the Complete Freund's Adjuvant (CFA) model.

    Main Results:

    • Carrageenan-induced hyperalgesic priming decreased nociceptor GRK2; ΨεRACK priming increased DRG EPAC1.
    • Increasing GRK2 or decreasing EPAC1 prevented chronic hyperalgesia in priming models.
    • Elevated GRK2 or reduced EPAC1 inhibited chronic hyperalgesia in the CFA model.

    Conclusions:

    • Nociceptor GRK2 and EPAC1 levels are critical in the transition to chronic pain.
    • Therapeutic strategies aimed at balancing GRK2 and EPAC1 show promise for chronic pain prevention and treatment.

    More Related Videos

    Intracranial Pharmacotherapy and Pain Assays in Rodents02:26

    Intracranial Pharmacotherapy and Pain Assays in Rodents

    Published on: April 9, 2019

    5.0K
    Chronic Post-Ischemia Pain Model for Complex Regional Pain Syndrome Type-I in Rats07:12

    Chronic Post-Ischemia Pain Model for Complex Regional Pain Syndrome Type-I in Rats

    Published on: January 21, 2020

    7.1K

    Related Concept Videos

    Analgesia and Pain Management01:25

    Analgesia and Pain Management

    Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
    3.4K
    Pain01:20

    Pain

    Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...
    2.1K
    GPCR Desensitization01:12

    GPCR Desensitization

    G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
    6.2K
    GPCRs Regulate Adenylyl Cylase Activity01:09

    GPCRs Regulate Adenylyl Cylase Activity

    Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
    6.9K
    Nociception01:44

    Nociception

    Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
    28.4K